DONALD SINGER: HEALTH, ART AND SCIENCE: European cooperation on healthcare discussed at FPM-HPT conference at Erasmus University in Rotterdam
![Donald Singer on Twitter: "Liese Barbier discussing biosimilars at European Cooperation in Healthcare conference @ESHPM_EUR @FPGMed https://t.co/lPNMEtc099 https://t.co/TRfHS2rrey" / Twitter Donald Singer on Twitter: "Liese Barbier discussing biosimilars at European Cooperation in Healthcare conference @ESHPM_EUR @FPGMed https://t.co/lPNMEtc099 https://t.co/TRfHS2rrey" / Twitter](https://pbs.twimg.com/media/D9ljlVAXUAAT4OI.jpg)
Donald Singer on Twitter: "Liese Barbier discussing biosimilars at European Cooperation in Healthcare conference @ESHPM_EUR @FPGMed https://t.co/lPNMEtc099 https://t.co/TRfHS2rrey" / Twitter
What the pharmacist needs to know when selecting biosimilar monoclonal antibodies in oncology: the case of trastuzumab biosimila
![European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption | SpringerLink European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40259-020-00452-9/MediaObjects/40259_2020_452_Fig1_HTML.png)
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption | SpringerLink
![Liese BARBIER | Postdoctoral researcher | PharmD, PhD | KU Leuven, Leuven | ku leuven | Department of Pharmaceutical and Pharmacological Sciences | Research profile Liese BARBIER | Postdoctoral researcher | PharmD, PhD | KU Leuven, Leuven | ku leuven | Department of Pharmaceutical and Pharmacological Sciences | Research profile](https://www.researchgate.net/profile/Liese-Barbier/publication/351812695/figure/tbl1/AS:1026949493321741@1621855247476/A-selection-of-criteria-to-consider-and-avoid-in-tender-procedures-A-Selection-of_Q320.jpg)
Liese BARBIER | Postdoctoral researcher | PharmD, PhD | KU Leuven, Leuven | ku leuven | Department of Pharmaceutical and Pharmacological Sciences | Research profile
![DONALD SINGER: HEALTH, ART AND SCIENCE: European cooperation on healthcare discussed at FPM-HPT conference at Erasmus University in Rotterdam DONALD SINGER: HEALTH, ART AND SCIENCE: European cooperation on healthcare discussed at FPM-HPT conference at Erasmus University in Rotterdam](https://thefpmuk.files.wordpress.com/2019/06/img_7034.jpg)
DONALD SINGER: HEALTH, ART AND SCIENCE: European cooperation on healthcare discussed at FPM-HPT conference at Erasmus University in Rotterdam
REALITYCHECK. 'Drag Race Belgique' bolt verder en 'Big Brother'-deelneemster Liese deelt sexy kiekjes | REALITYCHECK | hln.be
![News & events - The MABEL FUND - Market Analysis of Biologics and Biosimilars following Loss of Exclusivity News & events - The MABEL FUND - Market Analysis of Biologics and Biosimilars following Loss of Exclusivity](https://gbiomed.kuleuven.be/english/research/50000715/52577001/mabel/images/ibn.jpg/@@images/image/preview)
News & events - The MABEL FUND - Market Analysis of Biologics and Biosimilars following Loss of Exclusivity
![PhD defence Liese Barbier 4 - The MABEL FUND - Market Analysis of Biologics and Biosimilars following Loss of Exclusivity PhD defence Liese Barbier 4 - The MABEL FUND - Market Analysis of Biologics and Biosimilars following Loss of Exclusivity](https://gbiomed.kuleuven.be/english/research/50000715/52577001/mabel/images/liese-barbier-doctoraat-147.jpg/image_preview)
PhD defence Liese Barbier 4 - The MABEL FUND - Market Analysis of Biologics and Biosimilars following Loss of Exclusivity
![Liese BARBIER | Postdoctoral researcher | PharmD, PhD | KU Leuven, Leuven | ku leuven | Department of Pharmaceutical and Pharmacological Sciences | Research profile Liese BARBIER | Postdoctoral researcher | PharmD, PhD | KU Leuven, Leuven | ku leuven | Department of Pharmaceutical and Pharmacological Sciences | Research profile](https://i1.rgstatic.net/ii/profile.image/568199730208768-1512480780931_Q512/Liese-Barbier.jpg)